Clinical trial
The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section. A Prospective, Observational and Non-inferiority Study Against Epidural Analgesia.
Name
TRON
Description
It will be a prospective observational cohort study. The investigators will compare post-cesarean section recovery in patients receiving intravenous infusion of tramadol-ondansetron versus epidural catheter with infusion of local anesthetics.
Trial arms
Trial start
2023-05-23
Estimated PCD
2024-02-28
Trial end
2024-02-28
Status
Recruiting
Treatment
Tramadol-ondansetron continuous infusion
Analgesia strategy determined by routine use according to protocols, without investigator intervention.
Arms:
TRON (Tramadol-Ondansetron)
Ropivacaine via epidural catheter
Analgesia strategy determined by routine use according to protocols, without investigator intervention.
Arms:
AL-EPI (Local anesthetics via epidural)
Size
312
Primary endpoint
Post-surgical recovery
Day 1
Eligibility criteria
Inclusion Criteria:
* Woman over 18 years old undergoing caesarean section
* She agrees to participate voluntarily.
* She is already receiving any of the analgesic strategies studied.
Exclusion Criteria:
* Receiving an analgesic medication other than the one mentioned as "routine multimodal analgesia" (either as regular medication or for acute post-surgical pain)
* Medical history that determines the baseline data of the scales and data that we collect ( pain or previous disabilities; addiction to drugs, alcohol or drugs; another disease that worsens the quality of life)
* Medical history that conditions the pharmacological effect (allergy, intolerance or atypical reaction to any of the drugs involved in its treatment or possible cross-reactions )
* Contraindication for neuraxial techniques (patient refusal, difficulty in understanding or communication, localized infection, increased intracranial pressure, or other medical criteria)
* Two or more previous caesarean sections
* Difficulty in understanding or communication
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'COHORT', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 312, 'type': 'ESTIMATED'}}
Updated at
2023-05-30
1 organization
2 products
9 indications
Organization
Hospital Universitario La FeProduct
Tramadol-OndansetronIndication
Postoperative PainIndication
c-sectionIndication
TramadolIndication
Postoperative RecoveryIndication
Quality of RecoveryIndication
OndansetronIndication
QoR-15Indication
ObsQor-10Indication
Post-cesarean RecoveryProduct
Ropivacaine